Functional Brain Imaging Using a Long Intravenous Half-Life Gadolinium-Based Contrast Agent

References

1. ↵
   Hyder F, Kida I, Behar KL, et al. Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI. NMR Biomed 2001;14:413–31

   CrossRefPubMedWeb of Science
2. Arthurs OJ, Boniface S. How well do we understand the neural origins of the fMRI BOLD signal? Trends Neurosci 2002;25:27–31

   CrossRefPubMedWeb of Science
3. Arthurs OJ, Williams EJ, Carpenter TA, et al. Linear coupling between functional magnetic resonance imaging and evoked potential amplitude in human somatosensory cortex. Neuroscience 2000;101:803–06

   CrossRefPubMedWeb of Science
4. Glover GH, Lemieux SK, Drangova M, et al. Decomposition of inflow and blood oxygen level-dependent (BOLD) effects with dual-echo spiral gradient-recalled echo (GRE) fMRI. Magn Reson Med 1996;35:299–308

   PubMed
5. ↵
   Hoge RD, Atkinson J, Gill B, et al. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 1999;42:849–63

   CrossRefPubMedWeb of Science
6. ↵
   Mandeville JB, Marota JJ, Kosofsky BE, et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 1998;39:615–24

   PubMedWeb of Science
7. ↵
   Morii S, Ngai AC, Winn HR. Reactivity of rat pial arterioles and venules to adenosine and carbon dioxide: with detailed description of the closed cranial window technique in rats. J Cereb Blood Flow Metab 1986;6:34–41

   PubMedWeb of Science
8. ↵
   Hyder F, Behar KL, Martin MA, et al. Dynamic magnetic resonance imaging of the rat brain during forepaw stimulation. J Cereb Blood Flow Metab 1994;14:649–55

   PubMedWeb of Science
9. ↵
   Morton DW, Maravilla KR, Meno JR, et al. Clinically relevant rat model for testing BOLD functional MR imaging techniques by using single-shot echo-planar imaging at 1.5 T. Radiology 2001;218:598–601

   PubMed
10. ↵
    Macwhinney B, Cohen J, Provost J. The PsyScope experiment-building system. Spat Vis 1997;11:99–101

    PubMedWeb of Science
11. ↵
    Parmelee DJ, Walovitch RC, Ouellet HS, et al. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997;32:741–47

    CrossRefPubMedWeb of Science
12. Caravan P, Cloutier NJ, Greenfield MT, et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 2002;124:3152–62

    CrossRefPubMedWeb of Science
13. ↵
    Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529–38

    PubMedWeb of Science
14. ↵
    Lauffer RB, Parmalee DJ, Ouellet HS, et al. MS-325: a small-molecule vascular imaging agent for MR imaging. Acad Radiol 1996;3:S356–58

    CrossRefPubMed
15. ↵
    Bluemke DA, Stillman AE, Bis KG, et al. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 2001;219:114–22

    CrossRefPubMed